Rapilif D 4/0.5 Capsule
Prescription Required
10 Capsule
Manufacturer
Ipca laboratories ltdStorage
Store below 30°C
- Rapilif D 4/0.5 Capsule is used in the prevention of Benign prostatic hyperplasia.
- Rapilif D 4/0.5 Capsule prevents symptoms like urgent urination.
- Details
- Benefits
- Side effects
Rapilif D 4/0.5 Capsule is a medication combination used to treat the symptoms of benign prostatic hyperplasia (BPH) in people who have an enlarged prostate gland. Rapilif D 4/0.5 Capsule helps in the relief of symptoms such as trouble peeing or the need to urinate more frequently, as well as the improvement of your capacity to urinate. A small, muscular gland, the prostate is a part of the male reproductive system. BPH refers to prostate enlargement, which is a prevalent disorder in males between the ages of 50 and 60. It happens when the prostate gland's cells begin to proliferate. The bladder wall thickens with an enlarged prostate gland, and the bladder may weaken and lose its capacity to empty completely, leaving some pee in the bladder.
Usage instructions-
- The dose and duration of Rapilif D 4/0.5 Capsule should be taken as directed by your doctor.
How it works-
Adults with an enlarged prostate gland may be treated for the symptoms of benign prostatic hyperplasia (BPH) with Rapilif D 4/0.5 Capsule, a combination of dutasteride and silodosin. Silodosin is a member of a class of alpha-1 receptor blockers, which are found in the bladder and prostate. By preventing the activation of alpha-1 receptors, silodosin relaxes the smooth muscles in the bladder and prostate. Dutasteride is a member of the 5-alpha reductase class of medications that reduces the size of the prostate gland by inhibiting the activity of a 5-alpha reductase enzyme. Taking Rapilif D 4/0.5 Capsule helps you urinate more easily and lessens the symptoms of BPH.
Safety information-
Pregnancy
There are no instructions found in terms of pregnancy. You should consult your doctor.
Breastfeeding
There are no instructions found in this case. You should consult your doctor.
Alcohol
It may cause excessive drowsiness to consume alcohol with Rapilif D 4/0.5 Capsule.
Driving
Rapilif D 4/0.5 Capsule may impair your alertness, impair your eyesight, or make you drowsy and dizzy. If you have any of these symptoms, do not drive.
Kidney
Rapilif D 4/0.5 Capsule should be administered with caution to patients with kidney disease. Dose adjustments may be necessary. Please consult your doctor.
Liver
Rapilif D 4/0.5 Capsule should be administered with caution to patients with liver issues. Dose adjustments may be necessary. Please consult your doctor.
Rapilif D 4/0.5 Capsule is a medication combination of Silodosin and Dutasteride that is used to treat the symptoms of benign prostatic hyperplasia (BPH) in people with an enlarged prostate gland. Silodosin is an alpha-1 receptor (found in the prostate and bladder) blocker that produces smooth muscle relaxation in the bladder and prostate by inhibiting the function of alpha-1 receptors. Dutasteride is a 5-alpha reductase inhibitor that works by inhibiting the function of a 5-alpha reductase enzyme, causing the prostate gland to shrink Rapilif D 4/0.5 Capsule relieves BPH symptoms and improves urination.
- Diarrhea
- Headache
- Nasal congestion
- Dizziness
- Impotence
- Orthostatic hypotension